Carcinogenesis, Vol. 22, No. 5, 701-707,
May 2001
© 2001 Oxford University Press
CANCER BIOLOGY |
Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells
Laboratory of Cell Growth, Veterans Affairs Medical Center-San Francisco and Department of Medicine, University of California-San Francisco, 4150 Clement Street, San Francisco, CA 94121, USA
It has been proposed that the 
-6 fatty acids increase the rate of tumor growth. Here we test that hypothesis in the PC-3 human prostate tumor. We found that the essential fatty acids, linoleic acid (LA) and arachidonic acid (AA), and the AA metabolite PGE2 stimulate tumor growth while oleic acid (OA) and the -3 fatty acid, eicosapentaenoic acid (EPA) inhibited growth. In examining the role of AA in growth response, we extended our studies to analyze changes in early gene expression induced by AA. We demonstrate that c-fos expression is increased within minutes of addition in a dose-dependent manner. Moreover, the immediate early gene cox-2 is also increased in the presence of AA in a dose-dependent manner, while the constitutive cox-1 message was not increased. Three hours after exposure to AA, the synthesis of PGE2 via COX-2 was also increased. Previous studies have demonstrated that AA was primarily delivered by low density lipoprotein (LDL) via its receptor (LDLr). Since it is known that hepatomas, acute myelogenous leukemia and colorectal tumors lack normal cholesterol feedback, we examined the role of the LDLr in growth regulation of the PC-3 prostate cancer cells. Analysis of ldlr mRNA expression and LDLr function demonstrated that human PC-3 prostate cancer cells lack normal feedback regulation. While exogenous LDL caused a significant stimulation of cell growth and PGE2 synthesis, no change was seen in regulation of the LDLr by LDL. Taken together, these data show that normal cholesterol feedback of ldlr message and protein is lost in prostate cancer. These data suggest that unregulated over-expression of LDLr in tumor cells would permit increased availability of AA, which induces immediate early genes c-fos and cox-2 within minutes of uptake.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. J. Assinder, Q. Dong, H. Mangs, and D. R. Richardson Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-{beta} Pathways in Prostate Cancer Mol. Pharmacol., March 1, 2009; 75(3): 429 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Mack, V. Beljanski, A. M. Soulika, D. M. Townsend, C. B. Brown, W. Davis, and K. D. Tew "Skittish" Abca2 Knockout Mice Display Tremor, Hyperactivity, and Abnormal Myelin Ultrastructure in the Central Nervous System Mol. Cell. Biol., January 1, 2007; 27(1): 44 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Monjazeb, K. P. High, A. Connoy, L. S. Hart, C. Koumenis, and F. H. Chilton Arachidonic acid-induced gene expression in colon cancer cells Carcinogenesis, October 1, 2006; 27(10): 1950 - 1960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hughes-Fulford, C.-F. Li, J. Boonyaratanakornkit, and S. Sayyah Arachidonic Acid Activates Phosphatidylinositol 3-Kinase Signaling and Induces Gene Expression in Prostate Cancer Cancer Res., February 1, 2006; 66(3): 1427 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Chan, P. H. Gann, and E. L. Giovannucci Role of Diet in Prostate Cancer Development and Progression J. Clin. Oncol., November 10, 2005; 23(32): 8152 - 8160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hughes-Fulford, R. R. Tjandrawinata, C.-F. Li, and S. Sayyah Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells Carcinogenesis, September 1, 2005; 26(9): 1520 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Edwards, I. M. Berquin, H. Sun, J. T. O'Flaherty, L. W. Daniel, M. J. Thomas, L. L. Rudel, R. L. Wykle, and Y. Q. Chen Differential Effects of Delivery of Omega-3 Fatty Acids to Human Cancer Cells by Low-Density Lipoproteins versus Albumin Clin. Cancer Res., December 15, 2004; 10(24): 8275 - 8283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-Q. Ding, J. L. Vaught, H. Yamauchi, and S. E. Lind Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: The potential importance of down-regulation of superoxide dismutase 1 expression Mol. Cancer Ther., September 1, 2004; 3(9): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. E.M. Dommels, M. M.G. Haring, N. G.M. Keestra, G. M. Alink, P. J. van Bladeren, and B. van Ommen The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE2 synthesis and cytotoxicity in human colorectal carcinoma cell lines Carcinogenesis, March 1, 2003; 24(3): 385 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ernst, M. Hergenhahn, M. Kenzelmann, C. D. Cohen, M. Bonrouhi, A. Weninger, R. Klaren, E. F. Grone, M. Wiesel, C. Gudemann, et al. Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate Carcinoma : A Gene Expression Analysis on Total and Microdissected Prostate Tissue Am. J. Pathol., June 1, 2002; 160(6): 2169 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Wallace Nutritional and Botanical Modulation of the Inflammatory Cascade--Eicosanoids, Cyclooxygenases, and Lipoxygenases-- As an Adjunct in Cancer Therapy Integr Cancer Ther, March 1, 2002; 1(1): 7 - 37. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Boutemmine, N. Bouchard, D. Boerboom, H. E. Jones, A. K. Goff, M. Dore, and J. Sirois Molecular Characterization of Canine Prostaglandin G/H Synthase-2 and Regulation in Prostatic Adenocarcinoma Cells in Vitro Endocrinology, March 1, 2002; 143(3): 1134 - 1143. [Abstract] [Full Text] [PDF]
|
|